KRAS and BRAF mutations modify adjuvant chemotherapy outcomes in early stage colorectal cancer
Abstract KRAS and BRAF V600E mutations are established biomarkers in metastatic colorectal cancer (CRC), but their predictive roles in early-stage disease remain uncertain. We aimed to determine whether KRAS and BRAF V600E mutations modify the association between adjuvant chemotherapy regimen and su...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Portfolio
2026-05-01
|
| Serier: | npj Precision Oncology |
| Online adgang: | https://doi.org/10.1038/s41698-026-01494-y |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|